The Effect of Active Exercise on Maintenance Haemodialysis Patients
Effect of Active Exercise on Nutritional and Inflammatory Status, Muscle Metabolism and Cardiovascular Events in Maintenance Haemodialysis Patients
1 other identifier
interventional
200
1 country
1
Brief Summary
The goal of this clinical trial is to discuss the effects of physical activity on nutrition, inflammation, muscle metabolism, and the occurrence of cardiovascular and cerebrovascular events in patients with maintenance haemodialysis. The main question it aims to answer is: can exercise improve nutritional and inflammatory status, enhance muscle strength, and reduce the incidence of cardiovascular and cerebrovascular events in patients with maintenance haemodialysis. Researchers will compared active exercise group to conventional treatment group to see the impact of exercise on maintenance haemodialysis patients. Participants will: Choose low-intensity aerobic exercise workouts such as walking (no less than 8,000 steps per day) or jogging, swimming, Tai Chi, etc., according to their individual conditions, for no less than 30 minutes at a time, at least 3 times per week, and the intensity of the exercise should be based on an RPE score of 12 to 16.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 31, 2024
CompletedFirst Posted
Study publicly available on registry
August 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedAugust 23, 2024
August 1, 2024
1.5 years
July 31, 2024
August 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Mid-upper arm circumference of the non-internal fistula side(AC)
Measure the circumference of the non-internal fistula at the midpoint of the upper arm using a soft tape measure, in centimetres
Baseline and half year, 1 year
triceps skin-fold thickness of the non-internal fistula side(TSF)
Measurement of the skinfold at the midpoint of the upper arm on the non-internal fistula side by using a skinfold thickness gauge, in centimetres
Baseline and half year, 1 year
upper arm muscle circumference of the non-internal fistula side(AMC)
AMC(cm)= AC(cm) - 3.14 x TSF(cm)
Baseline and half year, 1 year
calf circumference
Measure the calf circumference using a soft tape measure, in centimetres
Baseline and half year, 1 year
grip strength
Using a grip strength meter, with the patient seated and gripping the handle firmly with the palm of the non-internal fistulae side, measure twice and record the maximum grip strength value
Baseline and half year, 1 year
Incidence of cardiovascular and cerebrovascular events
Cardiovascular events include: heart failure episodes, sustained arrhythmias, myocardial infarction, and cerebrovascular events include: cerebral haemorrhage, cerebral infarction, transient ischaemic attack.
1 year
Secondary Outcomes (5)
prealbumin
Baseline and half year, 1 year
albumin
Baseline and half year, 1 year
haemoglobin
Baseline and half year, 1 year
blood lipids
Baseline and half year, 1 year
c-reactive protein
Baseline and half year, 1 year
Study Arms (2)
exercise group
EXPERIMENTALpatients were asked to choose walking (no less than 8000 steps per day) or low-intensity aerobic exercise such as jogging, swimming, Tai Chi, etc., according to their own conditions, for no less than 30 minutes each time, at least 3 times per week, and the intensity of the exercise was determined by the need to increase the frequency and depth of breathing during the exercise, and it was appropriate to feel slightly tired but not exhausted (RPE score 12-16). Exercise intensity should be at least 3 times a week, and the exercise intensity should be at a level that requires an increase in breathing rate and depth, allowing for dialogue and communication, slight sweating, and a feeling of being slightly tired but not exhausted (RPE score of 12 to 16).
Control group
NO INTERVENTIONonly receive conventional MHD treatment, no requirement for exercise.
Interventions
such as walking, jogging, swimming, Tai Chi, etc. It needs to be at a certain frequency and intensity
Eligibility Criteria
You may qualify if:
- MHD more than 3 months, 3 times per week, 3-4h each time;
- Urea clearance index (Kt/V) \>1.2;
- Stable condition, no serious infection, tumour and cardiovascular disease;
- Willing to join the study and sign the informed consent form.
You may not qualify if:
- Combined with serious heart and lung disease: such as repeated heart failure, severe arrhythmia, unstable angina pectoris, severe pericardial effusion, severe heart valve disease, hypertrophic cardiomyopathy, aortic coarctation, severe emphysema, pulmonary heart disease, severe pulmonary hypertension (average pressure of the pulmonary artery \> 55mmHg), etc.;
- Combined with chronic joints, muscles, or vascular disease can not be or is not suitable for regular exercise, such as cerebrovascular disease; combined chronic joint, muscle or vascular disease can not or are not suitable for regular exercise, such as cerebrovascular disease sequelae, serious lower limb joint damage, severe myopathy, deep vein thrombosis, etc.;
- unwilling to cooperate with the movement of people
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yunfeng Xialead
Study Sites (1)
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 31, 2024
First Posted
August 23, 2024
Study Start
January 1, 2024
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
August 23, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share